Geratherm Medical AG (GME.DE)
EUR 2.88
(-2.37%)
EUR 2.88
(-2.37%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 1.11 Million EUR | 8.57% |
| 2022 | 1.02 Million EUR | 207.67% |
| 2021 | 332.64 Thousand EUR | -83.74% |
| 2020 | 2.04 Million EUR | 605.63% |
| 2019 | 289.85 Thousand EUR | -74.87% |
| 2018 | 1.15 Million EUR | 69.7% |
| 2017 | 679.78 Thousand EUR | -69.61% |
| 2016 | 2.23 Million EUR | -17.19% |
| 2015 | 2.7 Million EUR | 60.56% |
| 2014 | 1.68 Million EUR | 26.13% |
| 2013 | 1.33 Million EUR | 11.69% |
| 2012 | 1.19 Million EUR | 9.05% |
| 2011 | 1.09 Million EUR | -56.92% |
| 2010 | 2.54 Million EUR | -5.09% |
| 2009 | 2.67 Million EUR | 191.71% |
| 2008 | -2.92 Million EUR | 0.0% |
| 2007 | - EUR | 0.0% |
| 2006 | - EUR | -100.0% |
| 2005 | 1.42 Million EUR | 7.07% |
| 2004 | 1.33 Million EUR | -14.47% |
| 2003 | 1.55 Million EUR | 63.64% |
| 2002 | 952.13 Thousand EUR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 Q2 | 352.71 Thousand EUR | 0.0% |
| 2023 Q1 | 352.71 Thousand EUR | 164.92% |
| 2023 FY | 1.11 Million EUR | 8.57% |
| 2023 Q4 | 202.86 Thousand EUR | 0.0% |
| 2023 Q3 | 202.86 Thousand EUR | -42.49% |
| 2022 Q2 | 148.29 Thousand EUR | -65.97% |
| 2022 Q1 | 435.73 Thousand EUR | 146.79% |
| 2022 FY | 1.02 Million EUR | 207.67% |
| 2022 Q4 | 133.14 Thousand EUR | -32.78% |
| 2022 Q3 | 198.07 Thousand EUR | 33.56% |
| 2021 Q2 | 198.55 Thousand EUR | -52.95% |
| 2021 Q1 | 422.01 Thousand EUR | -17.09% |
| 2021 Q4 | -931.18 Thousand EUR | -315.13% |
| 2021 Q3 | 432.85 Thousand EUR | 118.0% |
| 2021 FY | 332.64 Thousand EUR | -83.74% |
| 2020 Q1 | 287.2 Thousand EUR | 231.05% |
| 2020 Q2 | 751.78 Thousand EUR | 161.76% |
| 2020 Q3 | 497.33 Thousand EUR | -33.85% |
| 2020 Q4 | 509 Thousand EUR | 2.35% |
| 2020 FY | 2.04 Million EUR | 605.63% |
| 2019 FY | 289.85 Thousand EUR | -74.87% |
| 2019 Q4 | -219.15 Thousand EUR | -210.13% |
| 2019 Q1 | 582.1 Thousand EUR | 1809.73% |
| 2019 Q3 | 198.98 Thousand EUR | 1317.78% |
| 2019 Q2 | -16.34 Thousand EUR | -102.81% |
| 2018 Q3 | -9338.00 EUR | -101.36% |
| 2018 FY | 1.15 Million EUR | 69.7% |
| 2018 Q1 | 446.99 Thousand EUR | 200.86% |
| 2018 Q2 | 685.45 Thousand EUR | 53.35% |
| 2018 Q4 | 30.48 Thousand EUR | 426.42% |
| 2017 Q4 | -443.18 Thousand EUR | -269.52% |
| 2017 Q3 | 261.44 Thousand EUR | 8.62% |
| 2017 FY | 679.78 Thousand EUR | -69.61% |
| 2017 Q2 | 240.69 Thousand EUR | -61.23% |
| 2017 Q1 | 620.83 Thousand EUR | -30.13% |
| 2016 Q3 | 360.22 Thousand EUR | -52.06% |
| 2016 Q1 | 236.63 Thousand EUR | -72.82% |
| 2016 FY | 2.23 Million EUR | -17.19% |
| 2016 Q4 | 888.53 Thousand EUR | 146.66% |
| 2016 Q2 | 751.42 Thousand EUR | 217.55% |
| 2015 FY | 2.7 Million EUR | 60.56% |
| 2015 Q4 | 870.74 Thousand EUR | 12.56% |
| 2015 Q3 | 773.54 Thousand EUR | 58.51% |
| 2015 Q2 | 488.01 Thousand EUR | -14.23% |
| 2015 Q1 | 568.95 Thousand EUR | -2.97% |
| 2014 Q3 | 398.46 Thousand EUR | -21.42% |
| 2014 Q4 | 586.36 Thousand EUR | 47.15% |
| 2014 Q2 | 507.07 Thousand EUR | 166.24% |
| 2014 Q1 | 190.45 Thousand EUR | -73.18% |
| 2014 FY | 1.68 Million EUR | 26.13% |
| 2013 Q4 | 710 Thousand EUR | 1917.35% |
| 2013 Q3 | 35.19 Thousand EUR | -89.45% |
| 2013 Q2 | 333.5 Thousand EUR | 30.75% |
| 2013 Q1 | 255.07 Thousand EUR | -55.97% |
| 2013 FY | 1.33 Million EUR | 11.69% |
| 2012 Q3 | 161.38 Thousand EUR | -49.7% |
| 2012 Q4 | 579.37 Thousand EUR | 259.01% |
| 2012 FY | 1.19 Million EUR | 9.05% |
| 2012 Q1 | 132.59 Thousand EUR | 127.21% |
| 2012 Q2 | 320.83 Thousand EUR | 141.96% |
| 2011 Q4 | -487.24 Thousand EUR | -296.2% |
| 2011 Q3 | 248.33 Thousand EUR | -71.05% |
| 2011 Q1 | 387.22 Thousand EUR | -38.81% |
| 2011 FY | 1.09 Million EUR | -56.92% |
| 2011 Q2 | 857.8 Thousand EUR | 121.53% |
| 2010 FY | 2.54 Million EUR | -5.09% |
| 2010 Q4 | 632.83 Thousand EUR | 41.5% |
| 2010 Q3 | 447.24 Thousand EUR | -25.56% |
| 2010 Q2 | 600.78 Thousand EUR | -30.26% |
| 2010 Q1 | 861.42 Thousand EUR | -32.58% |
| 2009 Q2 | 829.56 Thousand EUR | 4050.33% |
| 2009 Q1 | 19.98 Thousand EUR | 0.0% |
| 2009 Q3 | 558.57 Thousand EUR | -32.67% |
| 2009 FY | 2.67 Million EUR | 191.71% |
| 2009 Q4 | 1.27 Million EUR | 128.75% |
| 2008 FY | -2.92 Million EUR | 0.0% |
| 2008 Q2 | 172.24 Thousand EUR | 0.0% |
| 2007 FY | - EUR | 0.0% |
| 2006 FY | - EUR | -100.0% |
| 2005 FY | 1.42 Million EUR | 7.07% |
| 2004 FY | 1.33 Million EUR | -14.47% |
| 2003 FY | 1.55 Million EUR | 63.64% |
| 2002 FY | 952.13 Thousand EUR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| aap Implantate AG | -5.12 Million EUR | 121.681% |
| Drägerwerk AG & Co. KGaA | 110.43 Million EUR | 98.994% |
| Drägerwerk AG & Co. KGaA | 110.43 Million EUR | 98.994% |
| elexxion AG | -983.06 Thousand EUR | 213.029% |
| Eckert & Ziegler Strahlen- und Medizintechnik AG | 26.3 Million EUR | 95.775% |
| Koninklijke Philips N.V. | -466 Million EUR | 100.238% |
| Stratec SE | 13.06 Million EUR | 91.496% |
| Siemens Healthineers AG | 1.94 Billion EUR | 99.943% |